AGP Picks
View all

Today in Medicine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.

Press releases published on July 16, 2026

Soundbud Brings Adaptive Noise Cancellation to Open-Ear Earbuds with OpenAnc
NIH Continues Funding for High Point University Chemistry Research on Antibiotic Resistance
Kansas City University Review Highlights Astrocytes as Key Drivers of Chronic Traumatic Encephalopathy
A Steady Beat: How Metronome Therapy May Support Dementia Care Where the ACTIVE Study Falls Short
Lindsey McDaniels, MSN, RN, Pioneers Personalized Aesthetic Care at NV Regenerative Aesthetics in Denver
Five Reputable Liquid Silicone Rubber Manufacturers in China 2026: Advancing Silicone Material Innovation
Trethera and UCLA Publish Comprehensive Review Highlighting Deoxycytidine Kinase as a Novel Metabolic Target for Cancer Therapy
American Kidney Fund Expands Kidney Health Coach Program with Educational Course on Lupus Nephritis
NativePath 2026: Launch Effective Native Path Creatine Supplements for Seniors To Support Muscle Building and Strength with L-Leucine in USA
Canadian Red Cross supports communities impacted by Ottawa flooding
La Croix-Rouge canadienne vient en aide aux communautés frappées par les inondations à Ottawa
AUA Names Emily Clennon, MD, MPH, 2026-2027 H. Logan Holtgrewe Legislative Fellow
Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.
Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI
Gluten Free Products Market to Reach $19.2 Billion by 2031, Driven by Expanding Health Awareness and Product Innovation
Better Blend to open two new Cincinnati-area locations
Sonus Microsystems’ Autonomous Ultrasound AI Platform Selected for Major ARPA-H Maternal Health Award
Marius Pharmaceuticals Welcomes Department of Defense's New Testosterone Screening Initiative for U.S. Service Members
InnoCare Announces Phase II Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Vitiligo
SRX Global Regains Full Compliance with NYSE American Listing Standards

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Medicine

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.